|
Market Closed -
CBOE
23:00:00 15/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 8,641.79 HUF | 0.00% |
|
0.00% | +1.07% |
| 09-18 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 08-12 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
Company Valuation: Gedeon Richter PLC
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,619,625 | 1,542,290 | 1,627,029 | 1,893,161 | 1,799,226 | 2,296,297 | - | - |
| Change | - | -4.77% | 5.49% | 16.36% | -4.96% | 27.63% | - | - |
| Enterprise Value (EV) 1 | 1,559,769 | 1,395,557 | 1,546,536 | 1,782,343 | 1,588,618 | 2,033,821 | 1,886,286 | 1,759,317 |
| Change | - | -10.53% | 10.82% | 15.25% | -10.87% | 28.02% | -7.25% | -6.73% |
| P/E | 11.6x | 9.94x | 10.2x | 7.96x | 7.76x | 9.26x | 7.92x | 7.33x |
| PBR | 1.78x | 1.47x | 1.44x | 1.49x | 1.31x | 1.53x | 1.38x | 1.25x |
| PEG | - | 0.9x | 3.41x | 0.2x | -2.82x | 1.33x | 0.5x | 0.91x |
| Capitalization / Revenue | 2.57x | 1.92x | 2.02x | 2.21x | 1.94x | 2.41x | 2.25x | 2.1x |
| EV / Revenue | 2.47x | 1.74x | 1.92x | 2.08x | 1.71x | 2.14x | 1.85x | 1.61x |
| EV / EBITDA | 8.86x | 7.1x | 6.43x | 5.74x | 4.5x | 5.53x | 4.76x | 4.14x |
| EV / EBIT | 11.5x | 9.09x | 8.15x | 6.82x | 5.42x | 6.73x | 5.67x | 4.9x |
| EV / FCF | -460x | 12.3x | 17.9x | 8.26x | 7.56x | 9x | 8.22x | 7.11x |
| FCF Yield | -0.22% | 8.12% | 5.6% | 12.1% | 13.2% | 11.1% | 12.2% | 14.1% |
| Dividend per Share 2 | 225 | 390 | - | - | - | 603.6 | 677 | 738.7 |
| Rate of return | 2.58% | 4.7% | - | - | - | 4.79% | 5.38% | 5.87% |
| EPS 2 | 751 | 835 | 860 | 1,307 | 1,271 | 1,359 | 1,589 | 1,718 |
| Distribution rate | 30% | 46.7% | - | - | - | 44.4% | 42.6% | 43% |
| Net sales 1 | 630,595 | 802,755 | 805,158 | 857,545 | 928,962 | 951,368 | 1,020,834 | 1,093,689 |
| EBITDA 1 | 176,123 | 196,480 | 240,625 | 310,678 | 353,314 | 367,576 | 396,366 | 425,015 |
| EBIT 1 | 135,832 | 153,555 | 189,817 | 261,157 | 292,851 | 302,220 | 332,887 | 359,032 |
| Net income 1 | 139,626 | 155,581 | 158,850 | 239,244 | 232,335 | 254,304 | 290,549 | 314,929 |
| Net Debt 1 | -59,856 | -146,733 | -80,493 | -110,818 | -210,608 | -262,476 | -410,012 | -536,980 |
| Reference price 2 | 8,725.00 | 8,300.00 | 8,750.00 | 10,400.00 | 9,865.00 | 12,590.00 | 12,590.00 | 12,590.00 |
| Nbr of stocks (in thousands) | 185,630 | 185,818 | 185,946 | 182,035 | 182,385 | 182,391 | - | - |
| Announcement Date | 2/3/22 | 28/2/23 | 29/2/24 | 7/4/25 | 27/2/26 | - | - | - |
1HUF in Million2HUF
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 34.58x | 12.46x | 26.12x | 0.57% | 1,077B | |
| 37.53x | 6.26x | 17.55x | 2.1% | 612B | |
| 36.12x | 8.31x | 17.13x | 2.45% | 501B | |
| 113.84x | 6x | 25.7x | 2.32% | 364B | |
| 20.01x | 4.88x | 12.13x | 2.7% | 353B | |
| 20.46x | 5.37x | 13.21x | 2.96% | 278B | |
| 21.15x | 4.27x | 12.26x | 2.07% | 251B | |
| 27.06x | 6.97x | 12.48x | 2.37% | 230B | |
| -44.86x | 6.85x | 26.64x | 2.14% | 190B | |
| Average | 29.54x | 6.82x | 18.14x | 2.19% | 428.5B | |
| Weighted average by Cap. | 35.12x | 7.99x | 19.65x | 1.87% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RICHTER Stock
- 0QFP Stock
- Valuation Gedeon Richter PLC
Select your edition
All financial news and data tailored to specific country editions
